Study on Neurodegeneration Using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经退行性疾病研究
基本信息
- 批准号:8575341
- 负责人:
- 金额:$ 33.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-01 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAmyotrophic Lateral SclerosisAnimal ModelApoptosisApoptoticAstrocytesAstrocytosisBiological AssayCandidate Disease GeneCellsCessation of lifeComplexCoupledDendritesDevelopmentDiseaseDisease ProgressionFoundationsGap JunctionsGenesGlutamatesLifeMediatingMediator of activation proteinMicroarray AnalysisModelingMotor NeuronsMusMutationNerve DegenerationNeurodegenerative DisordersNeurogliaNeuronsParalysedPathogenesisPrimary Cell CulturesProteinsQuality of lifeRattusReactionResearchRodentSignal TransductionSpinal CordSynapsesToxic effectTransgenic OrganismsUbiquitinbaseeffective therapyimprovedin vitro Modelin vivo Modelmotor neuron degenerationmutantneurotoxicitynoveloverexpressionparacrinepreventprogressive neurodegenerationprotein TDP-43receptorresponsetherapy developmentuptake
项目摘要
DESCRIPTION (provided by applicant): Amyotrophic lateral sclerosis (ALS) results from progressive degeneration of motor neurons. ALS inexorably progresses to paralysis and to death within an average of 5 years. Of the few treatments, none substantially prolongs life or improves the quality of life. A major hurdle to developing effective therapy for ALS is a limited understanding of the disease mechanisms. A recent advance in ALS research comes with the discovery of TDP- 43 proteinopathy and TDP mutation. When overexpressed in transgenic rodents, mutant TDP-43 causes progressive neurodegeneration accompanied by severe glial reaction. To dissect the mechanisms underlying neurodegeneration caused by TDP mutation, we have developed transgenic rats reversibly expressing mutant TDP-43 in neurons or in astrocytes. By microarray analysis, we also have identified candidate genes responsive to glial reaction in mutant TDP-43 transgenic rats. Using TDP-43 transgenic rats (in vivo model) and primary cell cultures (in vitro model) as complementary models, we will resolve the following critical questions regarding TDP-43 pathogenesis: 1) how glial reaction correlates with the neurodegeneration caused by TDP mutation; 2) whether presence of mutant TDP-43 in astrocytes accelerates glial activation; 3) what molecules mediate the propagation of glial reaction in response to TDP mutation; 4) how astrocytes expressing mutant TDP-43 produce neurotoxicity; 5) how expression of mutant TDP-43 in astrocytes affects onset and progression of ALS in transgenic rats; and 6) whether continuous presence of mutant TDP-43 is required for disease progression. Proposed studies will not only develop desirable animal models for ALS research, but also would establish a foundation for developing ALS therapies targeting astrocytes or mutant TDP-43.
描述(由申请人提供):肌萎缩性侧索硬化症(ALS)由运动神经元的进行性变性引起。ALS会在平均5年内无情地发展为瘫痪和死亡。在为数不多的治疗方法中,没有一种能显著延长生命或提高生活质量。开发有效治疗ALS的一个主要障碍是对疾病机制的理解有限。ALS研究的最新进展是TDP- 43蛋白质病和TDP突变的发现。当在转基因啮齿类动物中过表达时,突变TDP-43引起伴有严重神经胶质反应的进行性神经变性。为了剖析TDP突变引起的神经退行性变的机制,我们开发了在神经元或星形胶质细胞中可逆表达突变型TDP-43的转基因大鼠。通过微阵列分析,我们还确定了候选基因的突变TDP-43转基因大鼠胶质反应。使用TDP-43转基因大鼠(体内模型)和原代细胞培养物(体外模型)作为补充模型,我们将解决以下关于TDP-43发病机制的关键问题:1)胶质反应如何与TDP突变引起的神经变性相关; 2)星形胶质细胞中突变TDP-43的存在是否加速胶质活化; 3)什么分子介导响应TDP突变的胶质反应的传播; 4)表达突变TDP-43的星形胶质细胞如何产生神经毒性; 5)突变TDP-43在星形胶质细胞中的表达如何影响转基因大鼠ALS的发病和进展;和6)突变TDP-43的持续存在是否是疾病进展所必需的。拟议的研究不仅将为ALS研究开发理想的动物模型,而且还将为开发针对星形胶质细胞或突变TDP-43的ALS疗法奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
hongxia zhou其他文献
hongxia zhou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('hongxia zhou', 18)}}的其他基金
STUDY ON NEURODEGENERATION USING TDP-43 TRANSGENIC RATS
TDP-43 转基因大鼠神经退行性研究
- 批准号:
10198111 - 财政年份:2020
- 资助金额:
$ 33.57万 - 项目类别:
Study on Neurodegeneration using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经变性研究
- 批准号:
9026917 - 财政年份:2015
- 资助金额:
$ 33.57万 - 项目类别:
Study on Neurodegeneration using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经变性研究
- 批准号:
9195755 - 财政年份:2015
- 资助金额:
$ 33.57万 - 项目类别:
Study on Neurodegeneration Using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经退行性疾病研究
- 批准号:
8392228 - 财政年份:2011
- 资助金额:
$ 33.57万 - 项目类别:
Study on Neurodegeneration Using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经退行性疾病研究
- 批准号:
8191524 - 财政年份:2011
- 资助金额:
$ 33.57万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 33.57万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 33.57万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 33.57万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
Fellowship














{{item.name}}会员




